This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Health Care Stocks With Upside

1. MediciNova is a Japan-based biopharmaceutical company engaged in the acquisition and development of low molecular pharmaceutical products for diseases with no effective treatment, mainly in the U.S. market. The company acquires pharmaceuticals from pharmaceutical companies in Japan and European countries.

Net loss for the fourth quarter is forecast at $5.1 million compared to net income of $5.9 million during fourth-quarter 2009, according to analysts polled by Bloomberg. Loss per share is seen at $1.62 for 2010, as opposed to $1.68 per share reported during 2009. For 2011, loss is likely to increase to $1.89 per share, analysts envisage. The company is expected to earn revenue of $50.2 million during 2014.

Earlier this month, the company signed a letter of intent regarding for forming a joint venture with Zhejiang Medicine Co. to develop and commercialize MN-221 in China. MN-221 is currently in Phase II development for the treatment for acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD) exacerbations in the U.S.

All the five analysts covering the stock recommend a buy on it. There are no sell ratings on the stock. Analysts polled by Bloomberg expect the stock to gain an average 226% to $11.72 in value from current levels.

>>To see these stocks in action, visit the 5 Health Care Stocks With Upside portfolio on Stockpickr.
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
NGSX $0.00 -28.57%
PARD $0.12 0.00%
CBLI $2.29 0.00%
DSCI $3.48 0.00%
MNOV $6.88 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs